Koch Industries Inc. Takes Position in Imperva Inc (IMPV)

Koch Industries Inc. acquired a new stake in shares of Imperva Inc (NASDAQ:IMPV) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,779 shares of the software maker’s stock, valued at approximately $229,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. SG Americas Securities LLC acquired a new position in Imperva in the 3rd quarter worth approximately $134,000. Quadrature Capital Ltd acquired a new position in Imperva in the 4th quarter worth approximately $224,000. Principal Financial Group Inc. increased its holdings in Imperva by 51.7% in the 3rd quarter. Principal Financial Group Inc. now owns 7,067 shares of the software maker’s stock worth $307,000 after buying an additional 2,409 shares during the period. Chicago Equity Partners LLC increased its holdings in Imperva by 35.9% in the 3rd quarter. Chicago Equity Partners LLC now owns 7,225 shares of the software maker’s stock worth $314,000 after buying an additional 1,910 shares during the period. Finally, Renaissance Group LLC acquired a new position in Imperva in the 4th quarter worth approximately $341,000.

How to Become a New Pot Stock Millionaire

Imperva stock traded down $0.50 during mid-day trading on Friday, hitting $43.80. The company had a trading volume of 232,840 shares, compared to its average volume of 386,324. Imperva Inc has a 12-month low of $37.17 and a 12-month high of $52.40. The firm has a market cap of $1,524.50, a PE ratio of -156.43 and a beta of 1.67.

Imperva (NASDAQ:IMPV) last announced its earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.13. Imperva had a negative return on equity of 3.28% and a net margin of 7.11%. The firm had revenue of $91.10 million for the quarter, compared to analyst estimates of $91.11 million. During the same quarter last year, the firm posted $0.32 EPS. The business’s revenue was up 16.2% on a year-over-year basis. sell-side analysts forecast that Imperva Inc will post -0.17 earnings per share for the current fiscal year.

Several equities analysts recently weighed in on the stock. BidaskClub downgraded shares of Imperva from a “buy” rating to a “hold” rating in a report on Thursday, March 29th. ValuEngine downgraded shares of Imperva from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Zacks Investment Research upgraded shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $53.00 price target on the stock in a report on Friday, February 16th. Imperial Capital increased their price target on shares of Imperva from $50.00 to $55.00 and gave the stock an “outperform” rating in a report on Friday, February 9th. Finally, Morgan Stanley increased their price target on shares of Imperva from $37.00 to $39.00 and gave the stock an “underweight” rating in a report on Friday, February 9th. Three analysts have rated the stock with a sell rating, five have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. Imperva currently has an average rating of “Hold” and a consensus target price of $53.00.

In other news, CRO Michael D. Mooney sold 24,454 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the transaction, the executive now owns 24,454 shares in the company, valued at approximately $1,153,739.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Anthony J. Bettencourt sold 66,037 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $46.98, for a total value of $3,102,418.26. Following the transaction, the director now owns 66,037 shares in the company, valued at approximately $3,102,418.26. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/08/5779-shares-in-imperva-inc-impv-acquired-by-koch-industries-inc.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Institutional Ownership by Quarter for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply